You decide not to prescribe Sildenafil in a patient because the patient is on an antianginal drug. Which of the following can it be?
The question states the patient is on an antianginal drug. Common antianginal drugs include nitrates like nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate. There's also nicorandil, which is a potassium channel opener but sometimes classified as a nitrate. Non-nitrate antianginals are beta-blockers, calcium channel blockers, and ranolazine.
So the correct answer here must be a nitrate. The options aren't provided, but the user's correct answer is likely one of the nitrates. Let's assume the options include nitroglycerin, which is a common nitrate. The other options would be non-nitrate antianginals like metoprolol (beta-blocker) or amlodipine (calcium channel blocker).
Nitrate drugs work by releasing nitric oxide, which activates guanylate cyclase, increasing cGMP and causing smooth muscle relaxation. Sildenafil inhibits PDE5, which normally breaks down cGMP. Combined, they lead to excessive cGMP accumulation, causing dangerous hypotension. This is a classic interaction that's crucial for exams like NEET PG or USMLE.
I need to make sure that the explanation clearly states the mechanism of interaction. Also, the incorrect options should be explained as non-nitrates. For example, if an option is a beta-blocker, it's a different class and doesn't interact with Sildenafil in this way. The clinical pearl here is to remember that any nitrate (including isosorbide derivatives) should not be combined with PDE5 inhibitors. The key takeaway is the nitrate-PDE5 interaction leading to hypotension.
**Core Concept**
Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, interacts dangerously with nitrates. Both drugs cause vasodilation via nitric oxide-cGMP pathways, leading to severe hypotension when combined. Antianginal nitrates like nitroglycerin are contraindicated with PDE5 inhibitors.
**Why the Correct Answer is Right**
Nitroglycerin (and other nitrates) release nitric oxide, activating guanylate cyclase to increase cGMP, causing smooth muscle relaxation. Sildenafil inhibits PDE5, which normally degrades cGMP. Together, they cause excessive cGMP accumulation, leading to uncontrolled vasodilation and life-threatening hypotension. This interaction is absolute contraindicated in clinical practice.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers (e.g., metoprolol) reduce myocardial oxygen demand but do not interact with Sildenafil via cGMP pathways.
**Option B:** Calcium channel blockers (e.g., amlodipine) may be safely combined with Sildenafil; they act on different mechanisms.
**Option C:** Ranolazine, a late sodium channel inhibitor